ADO Polyclonal Antibody
| Specifications | |
|---|---|
| Type: | Primary Antibody |
| Clonality: | Polyclonal |
| Host: | Rabbit |
| Reactivity: | Human, Mouse |
| Isotype: | IgG |
| Label: | Unconjugated |
| Concentration: | 0.3 mg/mL |
| Buffer: | PBS with 0.05% sodium azide and 50% glycerol, PH7.4 |
| Additional Information | |
|---|---|
| Synonyms: | 2 aminoethanethiol dioxygenase, 2-aminoethanethiol dioxygenase, ADO 2 aminoethanethiol (cysteamine) dioxygenase, ADO, AEDO, C10orf22, Chromosome 10 open reasing frame 22, cysteamine (2-aminoethanethiol) dioxygenase (ADO), Cysteamine dioxygenase, DKFZp564C046, FLJ14547 |
| Accn. No.: | NP_116193 |
| UniProt ID: | Q96SZ5 |
Applications
WB, IHC
Recommended Dilution
WB 1:1000-1:5000, IHC 1:25-1:100
Immunogen
Synthetic peptide of human ADO
Purification/Format
Affinity purification
Background
Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine. Mouse Ado has strong and specific dioxygenase activity in vitro towards cysteamine but not cysteine. Recombinant Ado was shown to bind iron. Overexpression of Ado in HepG2/C3A cells increased the production of hypotaurine from cysteamine. Similar results were found with human ADO. When endogenous expression of ADO was reduced by RNA-mediated interference, hypotaurine production decreased. The demonstration of high levels of ADO in brain challenges the previous assumption that most of the taurine in the brain is a consequence of CDO activity.
- Catalog Number
E-AB-15460-20ul-ELS - Supplier
Elabscience - Size
- Shipping
Blue Ice
Price
202,00 €
